0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

AEON Biopharma Inc.

Healthcare US AEON

1.54USD
-0.04(2.53%)

Last update at 2024-05-16T16:43:00Z

Day Range

1.501.60
LowHigh

52 Week Range

3.3711.88
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -52.55600M -55.63700M -32.91300M 145.67M
Minority interest - - 0.00000M 12.61M
Net income -52.55600M -55.63700M -32.91300M 172.92M
Selling general administrative 13.68M 11.15M 11.59M 46.04M
Selling and marketing expenses - - - -
Gross profit - - 2.52M 3.36M
Reconciled depreciation 0.07M 0.00300M 0.00000M 1.26M
Ebit -48.42900M -7.91500M -16.38800M -51.66700M
Ebitda -48.36100M -7.91200M -22.14200M -50.40900M
Depreciation and amortization 0.07M 0.00300M -5.75400M 1.26M
Non operating income net other - - - -
Operating income -48.42900M -65.84700M -16.38800M -53.96600M
Other operating expenses 48.43M 36.88M 18.91M 51.73M
Interest expense - - 0.01M 7.47M
Tax provision 0.00000M 0.00000M 0.00000M -14.64500M
Interest income - - 0.00000M 0.72M
Net interest income - - -0.01500M -6.75000M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - 28.97M 0.01M -14.64500M
Total revenue 0.00000M 0.00000M 2.52M 3.36M
Total operating expenses 48.43M 36.88M 18.91M 51.73M
Cost of revenue - - 0.00000M 0.00100M
Total other income expense net -4.12700M -18.75600M -16.51000M 200.79M
Discontinued operations - - - -
Net income from continuing ops -52.55600M -55.63700M -32.91300M 160.31M
Net income applicable to common shares -52.55600M -55.63700M -50.17200M 137.08M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 10.78M 6.44M 21.21M 114.35M
Intangible assets - - - -
Earning assets - - - -
Other current assets 0.09M 0.03M 0.21M 0.13M
Total liab 281.19M 230.26M 224.45M 180.22M
Total stockholder equity -287.50000M -234.94400M -208.27300M -67.15000M
Deferred long term liab - - 0.84M 0.78M
Other current liab 3.90M 4.01M 2.17M 1.68M
Common stock 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M
Retained earnings -474.83900M -422.28300M -366.64600M -333.73300M
Other liab - 0.22M 10.14M 9.62M
Good will - - - -
Other assets 0.03M 0.36M 0.84M 0.78M
Cash 9.75M 5.13M 20.17M 6.32M
Cash and equivalents - - - -
Total current liabilities 82.57M 20.80M 4.20M 17.50M
Current deferred revenue - - - -
Net debt 121.79M 81.76M 51.99M 23.63M
Short term debt 70.87M 15.60M - 14.79M
Short long term debt 70.87M 15.60M - 14.79M
Short long term debt total 131.53M 86.89M 72.16M 29.95M
Other stockholder equity 187.32M 187.32M 158.36M 266.57M
Property plant equipment 0.91M 0.92M - -
Total current assets 9.84M 5.15M 20.38M 112.14M
Long term investments - - 0.00000M 1.43M
Net tangible assets -287.50000M -234.94400M -208.27300M -67.15000M
Short term investments - - 0.00000M 105.42M
Net receivables - - 0.00000M 0.27M
Long term debt 60.43M 70.76M 72.16M 15.16M
Inventory - - - -
Accounts payable 7.80M 1.19M 2.03M 1.02M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.03M 0.36M 0.84M 0.78M
Deferred long term asset charges - - - -
Non current assets total 0.94M 1.28M 0.84M 2.21M
Capital lease obligations 0.24M 0.52M - -
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.30600M -0.17000M -1.26500M -117.29100M
Change to liabilities 6.61M -0.89800M 0.67M 3.92M
Total cashflows from investing activities -0.30600M -0.17000M -1.26500M -117.29100M
Net borrowings 40.51M 15.00M 25.11M 9.68M
Total cash from financing activities 40.51M 13.56M 24.57M 73.21M
Change to operating activities -0.34500M 2.31M 0.79M 3.54M
Net income -52.55600M -55.63700M -32.91300M 160.31M
Change in cash 4.62M -15.04000M 13.84M -88.80300M
Begin period cash flow 5.13M 20.17M 6.32M 95.13M
End period cash flow 9.75M 5.13M 20.17M 6.32M
Total cash from operating activities -35.58400M -28.43300M -9.46100M -44.72500M
Issuance of capital stock - - 0.00000M 77.80M
Depreciation 0.07M 0.00300M 0.00300M 1.26M
Other cashflows from investing activities - - - -
Dividends paid - - - 83.91M
Change to inventory - - 0.00000M -7.39300M
Change to account receivables - - -0.14800M -0.02400M
Sale purchase of stock - - 0.00000M -0.06400M
Other cashflows from financing activities 44.50M 13.56M 24.87M 69.71M
Change to netincome 10.64M 25.79M 22.00M -219.56100M
Capital expenditures 0.31M 0.17M 0.17M 1.69M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 6.27M 1.42M 1.45M 0.05M
Stock based compensation 5.89M 5.22M 4.79M 5.25M
Other non cash items 4.74M 20.57M 17.21M -196.95500M
Free cash flow -35.89000M -28.60300M -9.46100M -46.41900M

Fundamentals

  • Previous Close 1.58
  • Market Cap222.77M
  • Volume25622
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-56.41300M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-2.49

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AEON
AEON Biopharma Inc.		 -0.04 2.53% 1.54 - - 97.16 - 201.68 -3.9772
NVO
Novo Nordisk A/S		 -1.63 1.21% 133.03 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 0.57 0.43% 132.69 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 1.20 0.27% 438.69 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd		 1.03 1.09% 96.00 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

View All

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).